Protein Lipidation by Palmitoylation and Myristoylation in Cancer

被引:45
作者
Fhu, Chee Wai [1 ]
Ali, Azhar [1 ]
机构
[1] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore
关键词
protein lipidation; palmitoylation; myristoylation; depalmitoylation; metabolism; cancer; TRIS DIBENZYLIDENEACETONE DIPALLADIUM; N-MYRISTOYLTRANSFERASE; MEMBRANE-BINDING; DYNAMIC PALMITOYLATION; POTENT INHIBITORS; S-PALMITOYLATION; THIOESTERASES; DBA PALLADIUM; PALMOSTATIN B; FATTY-ACIDS;
D O I
10.3389/fcell.2021.673647
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Posttranslational modification of proteins with lipid moieties is known as protein lipidation. The attachment of a lipid molecule to proteins endows distinct properties, which affect their hydrophobicity, structural stability, localization, trafficking between membrane compartments, and influences its interaction with effectors. Lipids or lipid metabolites can serve as substrates for lipidation, and the availability of these lipid substrates are tightly regulated by cellular metabolism. Palmitoylation and myristoylation represent the two most common protein lipid modifications, and dysregulation of protein lipidation is strongly linked to various diseases such as metabolic syndromes and cancers. In this review, we present recent developments in our understanding on the roles of palmitoylation and myristoylation, and their significance in modulating cancer metabolism toward cancer initiation and progression.
引用
收藏
页数:15
相关论文
共 121 条
[1]   Identification and dynamics of the human ZDHHC 16-ZDHHC6 palmitoylation cascade [J].
Abrami, Laurence ;
Dallavilla, Tiziano ;
Sandoz, Patrick A. ;
Demir, Mustafa ;
Kunz, Beatrice ;
Savoglidis, Georgios ;
Hatzimanikatis, Vassily ;
van der Goot, F. Gisou .
ELIFE, 2017, 6
[2]  
Adibekian A., 2010, PROBES REPORT NIH MO
[3]   Confirming Target Engagement for Reversible Inhibitors in Vivo by Kinetically Tuned Activity-Based Probes [J].
Adibekian, Alexander ;
Martin, Brent R. ;
Chang, Jae Won ;
Hsu, Ku-Lung ;
Tsuboi, Katsunori ;
Bachovchin, Daniel A. ;
Speers, Anna E. ;
Brown, Steven J. ;
Spicer, Timothy ;
Fernandez-Vega, Virneliz ;
Ferguson, Jill ;
Hodder, Peter S. ;
Rosen, Hugh ;
Cravatt, Benjamin F. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (25) :10345-10348
[4]  
ALLAND L, 1994, J BIOL CHEM, V269, P16701
[5]   KRAS4A directly regulates hexokinase 1 [J].
Amendola, Caroline R. ;
Mahaffey, James P. ;
Parker, Seth J. ;
Ahearn, Ian M. ;
Chen, Wei-Ching ;
Zhou, Mo ;
Court, Helen ;
Shi, Jie ;
Mendoza, Sebastian L. ;
Morten, Michael J. ;
Rothenberg, Eli ;
Gottlieb, Eyal ;
Wadghiri, Youssef Z. ;
Possemato, Richard ;
Hubbard, Stevan R. ;
Balmain, Allan ;
Kimmelman, Alec C. ;
Philips, Mark R. .
NATURE, 2019, 576 (7787) :482-+
[6]   Targeting N-myristoylation for therapy of B-cell lymphomas [J].
Beauchamp, Erwan ;
Yap, Megan C. ;
Iyer, Aishwarya ;
Perinpanayagam, Maneka A. ;
Gamma, Jay M. ;
Vincent, Krista M. ;
Lakshmanan, Manikandan ;
Raju, Anandhkumar ;
Tergaonkar, Vinay ;
Tan, Soo Yong ;
Lim, Soon Thye ;
Dong, Wei-Feng ;
Postovit, Lynne M. ;
Read, Kevin D. ;
Gray, David W. ;
Wyatt, Paul G. ;
Mackey, John R. ;
Berthiaume, Luc G. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[7]   Targeting protein prenylation for cancer therapy [J].
Berndt, Norbert ;
Hamilton, Andrew D. ;
Sebti, Said M. .
NATURE REVIEWS CANCER, 2011, 11 (11) :775-791
[8]   Tris (Dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo [J].
Bhandarkar, Sulochana S. ;
Bromberg, Jacqueline ;
Carrillo, Carol ;
Selvakumar, Ponniah ;
Sharma, Rajendra K. ;
Perry, Betsy N. ;
Govindarajan, Baskaran ;
Fried, Levi ;
Sohn, Allie ;
Reddy, Kalpana ;
Arbiser, Jack L. .
CLINICAL CANCER RESEARCH, 2008, 14 (18) :5743-5748
[9]   (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase [J].
Bielawska, A ;
Greenberg, MS ;
Perry, D ;
Jayadev, S ;
Shayman, JA ;
McKay, C ;
Hannun, YA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12646-12654
[10]  
Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1